STERIS financials
$210.65−0.17%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q1 '27 Jun 30 | Q4 '26 Mar 31 | Q3 '26 Dec 31 | Q2 '26 Sep 30 | Q1 '26 Jun 30 | Q4 '25 Mar 31 | Q3 '25 Dec 31 | Q2 '25 Sep 30 | Q1 '25 Jun 30 | Q4 '24 Mar 31 | Q3 '24 Dec 31 | Q2 '24 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.59B | $1.50B | $1.46B | $1.39B | $1.48B | $1.37B | $1.33B | $1.28B | $1.42B | $1.30B | $1.24B |
| Gross profit | $684.2M | $697.2M | $655.5M | $645.9M | $628.0M | $641.2M | $610.4M | $578.8M | $572.4M | $582.9M | $560.0M | $546.2M |
| Gross margin | 45.8% | 43.9% | 43.8% | 44.2% | 45.1% | 43.3% | 44.5% | 43.6% | 44.7% | 41.1% | 43.2% | 44.1% |
| Operating income | $286.2M | $316.9M | $273.3M | $265.8M | $246.0M | $216.2M | $245.3M | $219.7M | $185.5M | $220.3M | $226.5M | $191.6M |
| Net income | $200.1M | $220.2M | $192.9M | $191.9M | $177.4M | $145.6M | $173.5M | $150.0M | $145.4M | -$1.4M | $140.7M | $115.3M |
| Net margin | 13.4% | 13.9% | 12.9% | 13.1% | 12.8% | 9.8% | 12.7% | 11.3% | 11.4% | −0.1% | 10.8% | 9.3% |
| Diluted EPS | $2.04 | $2.23 | $1.96 | $1.94 | $1.79 | $1.47 | $1.75 | $1.51 | $1.46 | $-0.01 | $1.42 | $1.16 |
| EBITDA | $410.0M | $440.0M | $395.7M | $389.7M | $367.2M | $353.8M | $373.4M | $337.8M | $323.9M | $410.6M | $367.1M | $343.8M |
| Operating cash flow | $367.1M | $335.5M | $298.2M | $287.7M | $420.0M | $260.9M | $332.7M | $250.8M | $303.7M | $254.8M | $291.2M | $146.1M |
| Free cash flow | $279.6M | $245.3M | $199.5M | $201.2M | $326.4M | $190.0M | $243.5M | $148.9M | $195.6M | $163.3M | $172.3M | $62.8M |
| Diluted shares | 97.9M | 98.6M | 98.6M | 98.8M | 98.8M | 98.9M | 98.9M | 99.2M | 99.4M | 99.6M | 99.4M | 99.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $482.3M | $439.6M | $423.7M | $319.2M | $279.7M | $171.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.89B | $1.93B | $1.90B | $1.90B | $1.90B | $2.04B |
| Total assets | $10.74B | $10.74B | $10.59B | $10.41B | $10.40B | $10.15B |
| Total liabilities | $3.51B | $3.54B | $3.42B | $3.39B | $3.44B | $3.53B |
| Shareholders' equity | $7.22B | $7.20B | $7.17B | $7.02B | $6.97B | $6.62B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology